Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health care and social assistance tags : Bicx104 save search
BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
Published: 2024-02-28 (Crawled : 16:00) - globenewswire.com
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 2.08%
H: 12.24%
C: 2.04%
bicx104 million treatment pharmaceuticals research grant implant
BioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder
Published: 2023-08-15 (Crawled : 13:00) - globenewswire.com
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 15.85%
H: 0.0%
C: 0.0%
bicx104 fda opioid treatment
BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
Published: 2023-07-18 (Crawled : 12:00) - globenewswire.com
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 8.6%
H: 9.9%
C: 9.41%
bicx104 fda opioid treatment application
BioCorRx Attended 4th Annual NIH HEAL Initiative Investigator Meeting; Shares Update on BICX104 Data
Published: 2023-02-23 (Crawled : 14:00) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
| Email alert
Add to watchlist
bicx104 update
BioCorRx Announces Completion of Treatment Phase of Study Subjects and Preliminary Safety Data from Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 3.25%
H: 0.0%
C: 0.0%
bicx104 treatment opioid trial study
BioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2022-10-13 (Crawled : 13:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -4.1%
H: 0.0%
C: 0.0%
bicx104 treatment opioid trial
BioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2022-06-30 (Crawled : 17:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 1.06%
H: 0.0%
C: 0.0%
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 6.44%
H: 0.81%
C: 0.81%
bicx104 treatment opioid trial
BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2022-04-27 (Crawled : 13:20) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
bicx104 treatment opioid trial
BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Published: 2022-03-16 (Crawled : 13:30) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 0.83%
H: 0.0%
C: 0.0%
bicx104 treatment implant order trial approval trex one opioid
BioCorRx Announces Orange County Research Center as Clinical Trial Site for First-In-Human Clinical Trial of BICX104
Published: 2022-02-14 (Crawled : 14:30) - biospace.com/
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 0.0%
H: 5.0%
C: 4.75%
bicx104 research trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
NYC 4 | $5.91 -4.83% 14.38% 770
|
Finance
MGOL 4 | $0.229 -4.18% 13.72% 420K
|
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K
|
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K
|
MGLD 4 | $1.23 8.85% 7.32% 14K
|
Manufacturing
GRFX | $0.2116 -1.58% 7.28% 40K
|
n/a
COMP | $3.24 -0.61% 6.48% 2.4M
|
Your saved searches
Save your searches and get alerts when important news are released.